Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 1998

View Archived Issues

Inspire enters into strategic partnership with Kissei

Pylorid-containing triple therapy effective in eradicating H. pylori

Matrix completes enrollment in IntraDose trials

Corixa's MUC-1 vaccine technology receives patent protection

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Positive clinical data from temozolomide trials presented at European oncology meeting

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Anthraquinone telomerase inhibitors developed at CRC Technology

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Organon designs novel acylguanidine-containing thrombin inhibitors

Joint venture for development of MPS I treatment now a reality

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Algos releases phase III clinical trial results for MorphiDex

Committee recommends approval of test to identify candidates for treatment with Herceptin

European-wide approval for Viagra

RPR will introduce CombiPatch in U.S. during third quarter

Novel treatment for breast cancer available for licensing

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

FDA clears diagnostic for DVT - a potentially life-threatening disorder

YM-75466 exerts antithrombotic effects at doses that do not alter bleeding and coagulation times

European marketing application for Myotrophin withdrawn

Bioniche receives EU registration for Cystistat

Biovail subsidiary will market clot buster in Canada

Cytogen's Cellcor subsidiary closes operations this week

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...